Your browser doesn't support javascript.
loading
Etoposide Amorphous Nanopowder for Improved Oral Bioavailability: Formulation Development, Optimization, in vitro and in vivo Evaluation.
Wang, Yue; Wang, Shuhang; Xu, Yingju; Wang, Ping; Li, Sukai; Liu, Lu; Liu, Mengyan; Jin, Xiangqun.
Affiliation
  • Wang Y; School of Pharmacy, Jilin University, Changchun, People's Republic of China.
  • Wang S; School of Pharmacy, Jilin University, Changchun, People's Republic of China.
  • Xu Y; School of Pharmacy, Jilin University, Changchun, People's Republic of China.
  • Wang P; School of Pharmacy, Jilin University, Changchun, People's Republic of China.
  • Li S; School of Pharmacy, Jilin University, Changchun, People's Republic of China.
  • Liu L; School of Pharmacy, Jilin University, Changchun, People's Republic of China.
  • Liu M; School of Pharmacy, Jilin University, Changchun, People's Republic of China.
  • Jin X; School of Pharmacy, Jilin University, Changchun, People's Republic of China.
Int J Nanomedicine ; 15: 7601-7613, 2020.
Article in En | MEDLINE | ID: mdl-33116490
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Compounding / Etoposide / Nanoparticles Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Int J Nanomedicine Year: 2020 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Compounding / Etoposide / Nanoparticles Type of study: Prognostic_studies / Risk_factors_studies Limits: Animals Language: En Journal: Int J Nanomedicine Year: 2020 Document type: Article